
CMMB
Healthcare · Biotechnology · $12.3M market cap
$1.56+0.17 (+11.8%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | — | -1.40 | — |
| Sep 24, 2026 | Time not confirmed | 0.00 | -1.40 | — |
| May 14, 2026 | Before the open | 0.00 | -0.00 | — |
| Nov 20, 2025 | Before the open | -0.04 | -0.00 | +90.0% |
| Aug 14, 2025 | Before the open | -0.04 | -0.02 | +50.0% |
| May 15, 2025 | Before the open | -0.20 | -0.14 | +30.0% |
| Mar 5, 2025 | Before the open | -0.01 | -0.01 | +20.0% |
| Nov 14, 2024 | Before the open | -0.04 | -0.04 | 0.0% |
| Aug 21, 2024 | Before the open | -0.04 | 0.05 | +225.0% |
| May 9, 2024 | Before the open | -0.06 | -0.06 | 0.0% |
| Mar 7, 2024 | Before the open | -0.02 | -0.27 | -1227.0% |
| Nov 9, 2023 | Before the open | -0.08 | -0.07 | +12.5% |
| Aug 14, 2023 | Before the open | -0.16 | -0.14 |
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating…
| +12.5% |
| May 11, 2023 | Before the open | -0.14 | -0.16 | -14.3% |
| Feb 21, 2023 | Before the open | -0.12 | -0.14 | -16.7% |
| Nov 10, 2022 | After the close | -0.92 | -0.14 | +84.8% |
| Aug 12, 2022 | Before the open | -0.72 | -0.11 | +84.7% |
| May 12, 2022 | Before the open | -0.68 | -0.09 | +86.8% |
| Mar 9, 2022 | Before the open | -0.10 | -0.44 | -340.0% |
| Nov 12, 2021 | Before the open | -0.06 | -0.05 | +16.7% |
| Aug 13, 2021 | Before the open | -0.46 | -0.05 | +89.1% |
| May 13, 2021 | Before the open | -1.72 | -0.04 | +97.7% |
| Mar 9, 2021 | After the close | -1.60 | -0.06 | +96.3% |
| Nov 16, 2020 | Before the open | -0.09 | -0.09 | 0.0% |
| Aug 14, 2020 | Before the open | -0.11 | -0.09 | +18.2% |
| May 7, 2020 | After the close | -1.84 | -8.00 | -334.8% |
| Mar 17, 2020 | Before the open | -2.00 | 31.20 | +1660.0% |
| Nov 15, 2019 | Before the open | -2.93 | -34.40 | -1074.1% |
| Aug 5, 2019 | After the close | -2.64 | -4.00 | -51.5% |
| May 22, 2019 | After the close | -2.56 | -56.00 | -2087.5% |
| Mar 12, 2019 | After the close | -0.15 | -0.12 | +20.0% |